CLINICAL TRIALS, STUDIES, REGISTRIES, DATA

Valar Labs’ CHAI Biomarkers Enhance Bladder Cancer Prediction | New Study in European Urology for Predicting Outcomes of High Grade Ta Bladder Cancer

The study finds that CHAI (Computational Histology AI) biomarkers stratify [...]

By |2025-06-13T17:14:05+00:00June 13, 2025|3rd Party Medical Device Industry News|Comments Off on Valar Labs’ CHAI Biomarkers Enhance Bladder Cancer Prediction | New Study in European Urology for Predicting Outcomes of High Grade Ta Bladder Cancer

Veracyte Announces Decipher Prostate Genomic Classifier Results are Linked to Real-World Data in National Cancer Institute’s SEER Specialized Database Release

Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today [...]

By |2025-04-21T22:20:27+00:00April 21, 2025|3rd Party Medical Device Industry News|Comments Off on Veracyte Announces Decipher Prostate Genomic Classifier Results are Linked to Real-World Data in National Cancer Institute’s SEER Specialized Database Release
Go to Top